As of 2026-03-25, the Relative Valuation of Marinus Pharmaceuticals Inc (MRNS) is (38.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.55 USD, the upside of Marinus Pharmaceuticals Inc based on Relative Valuation is -7189.1%.
The range of the Relative Valuation is (38.26) - (42.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 17.8x | 16.2x |
| Forward P/E multiples | 13.9x - 16.7x | 14.4x |
| Fair Price | (38.26) - (42.54) | (38.99) |
| Upside | -7057.2% - -7834.4% | -7189.1% |
| Date | P/E |